Delivery Order SPE2DB24D2205-SPE2DB25FEFZR
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,562,879,222 units of 1,000 MCG/ML Cyanocobalamin, a form of Vitamin B12, with a total ceiling value of $2,234.29. The contract has an ultimate completion date of November 22, 2023 and is a firm fixed-price contract. This delivery order is part of...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,505.75, is for the delivery of cyanocobalamin injection, a form of Vitamin B12. The contract has a period of performance through February 5, 2025 and is a firm fixed-price delivery order. No set-aside designation is mentioned. AmerisourceBergen holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at one hundred nine dollars and thirty-two cents ($109.32) to Amerisourcebergen Drug Corporation for the supply of one thousand (1,000) milligrams per milliliter vials of cyanocobalamin. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price contract spanning from July 7, 2023 through July 10, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,604.33 to AmerisourceBergen Drug Corp for Cyanocobalamin 500 MCG sprays, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $159,540 delivery order to Amerisourcebergen Drug Corporation for the supply of 1,000 mcg/ml cyanocobalamin vials. As the prime contractor, Amerisourcebergen will deliver the vitamin B12 injections from its Conshohocken, Pennsylvania facility by September 5, 2023 in fulfillment of this firm fixed price contract. No subcontractors or set aside designations were specified. The Defense Logistics Agency functions to support military readiness by procuring and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,117.72 to AmerisourceBergen Drug Corp for Cyanocobalamin 500 mcg sprays. This is a firm fixed-price, competitively awarded contract with no set-aside designation, issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,178.49, is for the delivery of 4,566,065,462 units of Cyanocobalamin (Vitamin B12) 500 mcg sprays. The contract has an ultimate completion date of October 10, 2024, and it is a firm-fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supports various government agencies and healthcare...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyanocobalamin 500 MCG sprays, with a ceiling value of $20,971.36 and a completion date of June 23, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Cyanocobalamin 500 MCG sprays. The contract is a firm fixed-price arrangement with a ceiling value of $19,155.72 and a period of performance through September 4, 2024. The award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, will provide these essential medical commodities to support military treatment facilities and...
- This is a $2,136.27 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vitamin D2 1.25mg (50,000 unit) medication in 100-count bottles. The award has an ultimate completion date of February 27, 2025. In addition to this delivery order, Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFZRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,903.09 to AmerisourceBergen Drug Corp for Cyanocobalamin 1,000 MCG/ML, a vitamin B12 pharmaceutical product. The contract, which carries a firm fixed price arrangement with no set-aside designation, was competitively awarded and is scheduled for completion by August 11, 2025. AmerisourceBergen will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement serves as the primary vehicle for pharmaceutical and medical supply distribution across the Defense Health Agency and military healthcare systems globally, encompassing a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The delivery order structure allows the agency to procure specific pharmaceutical items on an as-needed basis while maintaining consistent supplier relationships and pricing through the overarching IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/8/25 |